MDSpire - MDSpire Home
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

The Medicine Maker

  • August 17, 2026
Biopharma Labs Have an Integration Debt Problem
  • Mark Fish
  • August 17, 2026
  • 6 min
  1. Biopharma labs face integration debt as technology stacks grow faster than foundational architecture, complicating data management.
  2. The absence of integrations in lab systems leads to increased fragility and the need for manual data reconciliation.
  3. Cloud convergence allows labs to monitor experiments in real-time, improving intervention times and reducing costs.
  4. Successful lab automation requires strategic planning, training, and a focus on building digital fluency among scientists.
  5. Connected labs enable seamless data movement and collaboration, producing more trustworthy and reproducible results.
...more

Frontiers In Pain Research

  • August 17, 2026
Diverse Orthobiologics: A Mechanism-Focused Scoping Review of PRP, Cytokine-Enriched Serum, and Extracellular Vesicle Approaches in Musculoskeletal Disorders
  • Luigi Di Lorenzo
  • Alfonso M. Forte
  • Bruno De Meo
  • Francesco Forte
  • Carmine D'Avanzo
  • Hassan Zmerly
  • August 17, 2026
  1. Autologous blood-derived orthobiologics like PRP and cytokine-rich serum are widely used in musculoskeletal medicine.
  2. PRP operates mainly through growth factor release, while formulations with leukocytes focus on immune modulation.
  3. Acellular cytokine-rich sera provide immunomodulatory effects via soluble mediators, differing from cellular-based products.
  4. Extracellular vesicles, including exosomes, are experimental with unclear clinical efficacy and should not be conflated with PRP.
  5. A mechanism-focused classification system for orthobiologics is necessary to clarify their unique compositions and clinical applications.
...more

Frontiers In Endocrinology

  • August 17, 2026
Regional Regulation of Tight Junction Proteins in Luminal and Glandular Epithelial Cells of the Upper Reproductive Tract Throughout the Estrous Cycle
  • Donaldson A. Magloire
  • Haoming Liu
  • Heather L. Wilson
  • August 17, 2026
  1. The study evaluates the expression of Tight Junction proteins Claudin-3, Claudin-4, and ZO-1 in the porcine upper reproductive tract during estrus and diestrus.
  2. Claudin-4 expression significantly decreased in the distal uterine horn during estrus, while levels remained stable in the cervix across estrous stages.
  3. Claudin-3 showed a marked reduction during estrus in the glandular epithelium of the distal uterine horn and cervical luminal epithelium.
  4. The expression of ZO-1 remained largely unaffected by the estrous stage in all examined regions of the upper reproductive tract.
  5. The findings indicate that the regulation of Claudin-3 and Claudin-4 is stage-dependent and region-specific within the porcine reproductive tract.
...more

Frontiers In Medicine

  • August 17, 2026
Endobronchial Administration of Amphotericin B Deoxycholate as an Adjunctive Treatment for Pulmonary Mucormycosis Unresponsive to Posaconazole: A Retrospective Case Review
  • Liyan Qiu
  • Binyue Liang
  • Hua Zhou
  • August 17, 2026
  1. Pulmonary mucormycosis is a severe fungal infection primarily affecting immunocompromised individuals, often requiring systemic antifungal therapy.
  2. A retrospective review identified five patients with pulmonary mucormycosis who did not respond adequately to posaconazole-based therapy.
  3. Patients underwent bronchoscopic airway clearance followed by local administration of amphotericin B deoxycholate, with no reported adverse events.
  4. Follow-up CT scans showed partial absorption or shrinkage of pulmonary lesions in all five patients after local amphotericin B treatment.
  5. The study suggests that local amphotericin B deoxycholate may be a feasible adjunctive treatment for pulmonary mucormycosis unresponsive to posaconazole.
...more

Frontiers In Surgery

  • August 17, 2026
Concurrent Multiple Primary Colorectal Cancers with Divergent RAS Status in Primary Tumors: A Case Study of an Elderly Individual
  • Junting Guan
  • Jiyuan Chen
  • Shengqi Pan
  • Qi Li
  • Guiyu Wang
  • Qingchao Tang
  • August 17, 2026
  1. Synchronous multiple primary colorectal cancer (SMPCRC) is rare, comprising 1% to 8% of colorectal cancer cases, with multiple lesions occurring within six months.
  2. A 77-year-old male was diagnosed with four distinct colorectal lesions, including adenocarcinomas and a rectal adenoma with intramucosal carcinoma.
  3. Molecular testing revealed discordant RAS mutation statuses; the rectal lesion had mutations while the sigmoid colon lesion was RAS/RAF/PIK3CA wild-type.
  4. The patient underwent a multimodal treatment approach, including synchronous surgery, endoscopic dissection, and personalized chemotherapy adjustments.
  5. Eighteen months post-treatment, the patient showed no signs of recurrence and maintained a satisfactory general condition.
...more

Frontiers In Medicine

  • August 17, 2026
A Comprehensive Strategy for Addressing Residual Risk in Atherosclerotic Cardiovascular Disease in China Beyond Lipid Management
  • Ming Chi
  • Taoming Qian
  • Jirong Zhang
  • Weiqing Qiao
  • Juan Jin
  • August 17, 2026

Objective: To explore the residual risk in atherosclerotic cardiovascular disease (ASCVD) in China and propose a multimodal strategy for its assessment and mana

...more

Frontiers In Immunology

  • August 17, 2026
Smad4 and Eomes Interact in a Common Transcriptional Pathway Linked to Inflammatory CD8 T-Cell Differentiation
  • Karthik Chandiran
  • Nandu C. Karingari
  • Srineeharika Sirigineedi
  • Linda S. Cauley
  • August 17, 2026
  1. Smad4 and Eomes are critical transcription factors influencing CD8 T cell differentiation and protective immunity.
  2. Disruption of transcriptional pathways regulated by Smad4 and Eomes is linked to viral infections, chronic inflammation, and cancer.
  3. Smad4 and Eomes are essential for the differentiation of memory T cells, particularly tissue-resident memory (TRM) cells.
  4. An integrated analysis revealed overlapping and unique gene expression programs regulated by Smad4 and Eomes in CD8 T cells.
  5. Canonical TGF-beta signaling remains active without Smad4 or Eomes, becoming inactive only when both Smad3 and Smad4 are absent.
...more

Frontiers In Surgery

  • August 17, 2026
Evaluation of Distal Margin Measurements in Rectal Cancer Surgery: A Comparison of Fresh and Fixed Specimens
  • Akay Edizsoy
  • Orkhan Mirzayev
  • Hatice Barak
  • İbrahim Meteoğlu
  • Pars Tunçyürek
  • August 17, 2026
  1. The study analyzed distal margin measurements in rectal cancer specimens before and after formalin fixation.
  2. Mean distal margin decreased from 4.39 cm in fresh specimens to 3.90 cm post-fixation, reflecting a 13.2% shrinkage.
  3. Two specimens measured below 1 cm after fixation, although neither patient experienced local recurrence during follow-up.
  4. The findings suggest that formalin fixation can affect pathological assessment of distal margins in rectal cancer.
  5. Larger studies are needed to explore the clinical implications of margin shortening due to fixation.
...more

Frontiers In Immunology

  • August 17, 2026
Exploring the Role of Traditional Chinese Medicine in Sepsis-Related PICS: Insights into Immunometabolic Mechanisms and Clinical Implications
  • Pochen Li
  • Fangyu Yu
  • Er Hong
  • Yan Wu
  • Danxia Ge
  • Qianping Zhang
  • Yujiao Li
  • Yang Wu
  • August 17, 2026
  1. Persistent inflammation, immunosuppression, and catabolism syndrome (PICS) significantly contributes to long-term morbidity in sepsis survivors.
  2. Traditional Chinese medicine (TCM) is being explored as a complementary approach in critical care for managing sepsis-related PICS.
  3. Xuebijing injection has shown associations with improved short-term clinical outcomes and reduced inflammatory markers in sepsis patients.
  4. Existing studies primarily focus on the acute phase of sepsis, lacking sufficient evidence on TCM's role during the recovery phase associated with PICS.
  5. Methodological heterogeneity and variability in diagnostic definitions hinder the interpretation and generalizability of current findings on TCM in PICS.
...more

Frontiers In Oncology

  • August 17, 2026
Development and Clinical Assessment of a Colloidal Gold Immunochromatographic Assay for Thyroglobulin Detection
  • Qi Yang
  • Jifeng Li
  • Jinzi Hui
  • Jia Dai
  • Hongbian Gao
  • Yuan An
  • August 17, 2026

Objective: To develop a novel colloidal gold immunochromatographic assay (CGICA) for the rapid detection of thyroglobulin, facilitating the diagnosis of lymph n

...more

Frontiers In Reproductive Health

  • August 17, 2026
Association of Metal Exposure and Uterine Fibroid Prevalence in African Caribbean Women: Insights from the Tobago Health Study
  • Alexis Kiyanda
  • Hoimonty Mazumder
  • Iva Miljkovic
  • Ryan Cvejkus
  • Janet Catov
  • Victor Wheeler
  • Patrick J. Parsons
  • Elizabeth J. Mullin
  • Austin A. Roberts
  • Aaron Barchowsky
  • Natalie Price
  • Alison P. Sanders
  • August 17, 2026
  1. Uterine fibroids are the most common benign tumors in women, significantly contributing to hysterectomy rates.
  2. The study analyzed 441 African Caribbean women, focusing on the correlation between urinary metal concentrations and uterine fibroid prevalence.
  3. Higher urinary concentrations of arsenic and its metabolites were associated with increased odds of developing uterine fibroids.
  4. No significant associations were found between other metals or metal mixtures and the likelihood of uterine fibroids.
  5. Further longitudinal studies are needed to confirm these findings and guide public health policies regarding metal exposure.
...more

Frontiers In Medicine

  • August 17, 2026
Initial Presentation of Systemic Diffuse Large B-Cell Lymphoma as a Painful Penile Mass: A Case Study
  • Min-Jung Jan
  • Chia Hao Liang
  • Ming-Che Ou
  • Tang-Yi Tsao
  • Yi-Sheng Lin
  • Yen-Chuan Ou
  • Min-Che Tung
  • Chao-Yu Hsu
  • August 17, 2026
  1. Diffuse large B-cell lymphoma (DLBCL) of the penis is a rare malignancy often misdiagnosed as penile carcinoma or infections.
  2. A 58-year-old man presented with a painful penile mass that did not improve with antibiotics, leading to a biopsy confirming DLBCL.
  3. Imaging revealed intense uptake in the penis and gastric involvement, classifying the disease as Lugano stage IV.
  4. The patient was treated with R-CHOP systemic chemo-immunotherapy, achieving complete metabolic remission.
  5. This case highlights the importance of FDG PET/CT in diagnosing and staging DLBCL with extranodal involvement.
...more

Npj Digital Medicine

  • August 15, 2026
Advancing Artificial Intelligence in Healthcare: Key Policy Focus Areas from the 2025 HHS Information Request
  • David C. Klonoff
  • Agatha F. Scheideman
  • Mandy M. Shao
  • Juan Espinoza
  • August 15, 2026
  1. The HHS RFI seeks public feedback on AI integration in healthcare, focusing on regulation, reimbursement, and research enhancements.
  2. Key conclusions from the HHS guidance include fostering an industry-friendly regulatory framework and ensuring patient protections.
  3. AI applications in clinical care include tools for risk prediction, clinical decision support, medication management, and patient engagement.
  4. The RFI identifies diabetes as a case study for AI advancements, aiming to improve regulatory frameworks and reimbursement structures.
  5. Stakeholder feedback on the RFI is crucial for shaping future HHS policies on AI integration in healthcare by the February 23, 2026 deadline.
...more

Food Safety And Risk

  • August 15, 2026
Novel Active Edible Coating Utilizing Safflower (Carthamus tinctorius L.) Extract for Microbial Control and Prolonged Shelf Life of Cheese
  • Elif Ayça Güler
  • Elif Özbey
  • August 15, 2026
  1. Approximately one-third of food produced globally is lost or wasted annually during handling, storage, and transportation.
  2. Conventional petroleum-based packaging raises environmental concerns due to poor biodegradability and waste accumulation.
  3. Active edible coatings, such as those containing safflower extract, release bioactive compounds to manage microbial spoilage and oxidative deterioration.
  4. Edible coatings can enhance food quality and shelf life by acting as protective barriers that reduce moisture loss and preserve aroma.
  5. The application of edible coatings employs various techniques, with dipping being the most common for uniform coverage on food surfaces.
...more

Acta Neurochirurgica

  • August 15, 2026
Reply to: Methodological Issues in the Structural Analysis of Chiari Malformation Type 0
  • B. Candan
  • B. Ozkal
  • E. Top
  • August 15, 2026
  1. The classification of Chiari malformation type 0 (CM-0) is not universally recognized and is characterized by Chiari-like symptoms and minimal tonsillar descent.
  2. The study aimed to assess a broader range of CM-0 patients rather than replicate studies focusing solely on those with syringomyelia.
  3. None of the observed morphometric differences between CM-0 patients and controls achieved statistical significance after corrections for multiple comparisons.
  4. The authors acknowledge limitations in their study, including reliance on two-dimensional measurements and lack of standardized cerebrospinal fluid flow studies.
  5. Future research should explore morphometry, cerebrospinal fluid dynamics, and symptomatology to better understand the CM-0 classification.
...more

MDSpire News

  • August 14, 2026
FDA approves tau PET imaging agent
  • Kathryn Wighton
  • August 14, 2026
  • 2 min

Objective: To report the FDA approval of florquinitau F18 injection (TAUKLARIFY) for tau PET imaging in adults with cognitive impairment undergoing evaluation f

...more
2 min

MDSpire News

  • August 14, 2026
FDA approves iberdomide for multiple myeloma
  • Kathryn Wighton
  • August 14, 2026
  • 3 min
  1. The FDA granted accelerated approval to iberdomide for adults with multiple myeloma who had prior therapy including a proteasome inhibitor and an immunomodulatory agent.
  2. Iberdomide is the first cereblon E3 ligase modulator approved by the FDA and is part of the cereblon-modulating protein degrader class.
  3. The approval was based on the phase 3 EXCALIBER-RRMM trial, which compared iberdomide with daratumumab and dexamethasone to a standard regimen.
  4. At 16 months, 41% of patients receiving the iberdomide regimen achieved MRD-negative complete response compared to 21% in the control group.
  5. Iberdomide has serious adverse reactions, including pneumonia and infections, and carries boxed warnings for embryo-fetal toxicity and thromboembolism.
...more

Phoenix Children's Medical Connection

  • August 14, 2026
American Epilepsy Society Clinical Practice Guideline: Infantile Epilepsy
  • August 14, 2026
  • 2 min

Objective: To provide updated, evidence-based recommendations for the management of epilepsy in infants and children aged 1 month to Approach: Guideline Develop

...more
2 min